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ABSTRACT 
Previous studies report benefits of exercise for blood pressure control in middle age 
and older adults, but longer-term effectiveness in younger adults is not well 
established. We performed a systematic review and meta-analysis of published 
randomized control trials with meta-regression of potential effect modifiers. An 
information specialist completed a comprehensive search of available data sources, 
including studies published up to June 2015. Authors applied strict inclusion and 
exclusion criteria to screen 9524 titles. Eligible studies recruited younger adults with a 
cardiovascular risk factor (with at least 25% of cohort aged 18 to 40 years); the 
intervention had a defined physical activity strategy and reported blood pressure as 
primary or secondary outcome.  Meta-analysis included 14 studies randomizing 3614 
participants, mean age 42.2+/-6.3 (sd) years.  At 3 to 6 months, exercise was 
associated with a reduction in systolic blood pressure of –4.40 mmHg (95%CI, -5.78 
to -3.01) and in diastolic blood pressure of -4.17 mmHg (95%CI, -5.42 to -2.93). 
Intervention effect was not significantly influenced by baseline blood pressure, body 
weight or subsequent weight loss. Observed intervention effect was lost after 12 
months follow-up with no reported benefit over control, mean difference in systolic 
blood pressure -1.02 mmHg (95%CI, -2.34 to 0.29) and in diastolic blood pressure –
0.91 mmHg (95%CI, -1.85 to 0.02).  Current exercise guidance provided to reduce 
blood pressure in younger adults is unlikely to benefit long-term cardiovascular risk. 
There is need for continued research to improve age specific strategies and 
recommendations for hypertension prevention and management in young adults.  
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INTRODUCTION 
Population studies estimate 1 in 17 adults below the age of 40 years are hypertensive1 
with higher prevalence in those with diabetes, obesity, familial predisposition or 
prenatal and other early childhood factors.2–7 Hypertension in early life significantly 
increases the risk of stroke and cardiovascular disease before the age of 50 years.8–
11 However, rates of diagnosis are consistently lower in younger adults and, even when 
identified, control is frequently sub-optimal.5,12–14 This may relate to an acceptance of 
higher blood pressures due to a perceived lower 5 year cardiovascular risk, particularly 
for those in the pre-hypertensive range. This is despite epidemiological evidence of 
cumulative vascular protection and lower disease burden in later life following change 
in blood pressure and lifestyle during early adulthood.9,15–17 Together these 
observations may explain why 1 in 5 strokes still occur in the under 55 year age 
group.18   
To reduce burden of early stroke and cardiovascular disease, evidence based 
guidance is required to improve hypertension prevention and management for young 
adult populations. Exploring heterogeneity in response pattern to exercise and linking 
exercise response with hypertensive and cardiovascular phenotypes identifiable within 
younger subgroups may be of value in future studies and offer opportunity to deliver 
more personalised and targeted intervention strategies.  Current guidelines 
recommend specialist review of young adults with elevated blood pressure since the 
risk of hypertension may be underestimated in the under 40 age group.19  In the 
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absence of significant end organ disease or secondary causes of elevated blood 
pressure, young adults under 40 years old are encouraged to implement lifestyle 
changes, in particular regular exercise, as the first line for hypertension 
management.20,21  A limitation of this guidance is that it is based on data from physical 
activity trials in older populations with mean ages greater than 50 years.22,23 There are 
a number of potential modifiers of intervention effect which are not consistent across 
age groups including baseline physical activity,24 barriers to participation25 and 
physiological training adaptations.26 Therefore, we performed a new systematic review 
and meta-analysis to evaluate the quality of the evidence base and effectiveness of 
exercise intervention to reduce blood pressure in younger adult populations.  
METHODS 
Protocol registration: PROSPERO (www.crd.york.ac.uk/PROSPERO/) registration 
number CRD42014009604. 
Search strategy and selection criteria 
We completed a systematic review in accordance with established methods for 
Cochrane reviews of physical activity interventions (Supplement S1). We adhered to 
the Cochrane Handbook for Intervention Reviews and PRISMA statement 
(Supplement S2).  An information specialist (NR) searched the following databases: 
Cochrane Central Register of Controlled Trials, MEDLINE & MEDLINE In Process, 
EMBASE, CINAHL, AMED, PsycINFO, SPORTdiscus, OpenGrey, Science Citation 
Index & Conference Proceedings Citation Index-Science, ACM Digital Library and 
IEEE Xplore Digital Library. Cochrane highly sensitive search was used to identify 
randomized controlled trials. No language or date restrictions were applied. 
Bibliographies of review articles and selected articles were examined for relevant 
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trials. Literature searches completed up to June 2015. Full description of data sources 
and search summary available online (Supplement S1, Table S1). 
 
 
Study selection and data extraction 
We included studies with mean population age between 18 to 40 years old or within 
one standard deviation of this range to ensure at least 25% of the study population 
were younger than 40 years old. To be representative of young adults who may be 
provided advice to manage blood pressure, included studies were required to recruit 
participants with one or more cardiovascular risk factor, or family history of cardio-
metabolic risk. Risk factors included hypertension or pre-hypertension (systolic blood 
pressure ≥ 120 mmHg and/or diastolic blood pressure ≥ 80 mmHg), overweight (mean 
body mass index(BMI) > 25 kg/m2) but not severely obese (BMI ≥ 35 kg/m2), diabetes, 
metabolic syndrome, dyslipidaemia, smoking and alcohol consumption. The defined 
BMI exclusion criteria were based on the understanding that severely obese 
populations have higher burden of comorbidities and potential functional barriers to 
exercise participation that makes them a unique target audience. Studies examined 
the effectiveness of interventions with defined exercise, physical activity or 
cardiovascular fitness components. The comparator was a control group exposed to 
placebo, no and/or minimal intervention. Blood pressure was reported as a primary or 
secondary outcome after a minimum follow-up of 3 months. Studies were required to 
have over 80% complete follow-up data analysing the results by intention-to-treat or, 
if not applying intention to treat, ensuring less than 20% study attrition. Additional 
details on inclusion criteria provided in online supplement (Supplement S1).  
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Titles and abstracts were screened independently by paired authors (WW, HR, AL, 
PK). Two authors (WW, HR) independently reviewed full text articles and extracted 
data. Study inclusion was agreed by consensus in discussion with other authors (CF, 
PL). Missing or ambiguous data was clarified with the corresponding author.  We 
assessed risk of bias for studies that met inclusion criteria for meta-analysis using the 
Cochrane Risk of Bias Tool which was expanded to include risk areas specific for 
physical activity and blood pressure interventions (Supplement S1). Quality of included 
studies were summarised using the GRADE approach.27 
Statistical analysis 
Studies were analysed using mean and standard deviation (SD) of outcomes 
expressed in the original papers. Clinic blood pressures, measured at rest, were 
reported across all studies and used as the outcome measures.  We expressed effect 
size using the mean difference between the post-intervention values of the 
randomized groups. If required we imputed standard deviations from standard errors 
and confidence intervals using methods described in the Cochrane handbook.27 When 
studies investigated multiple interventions arms, intervention arms inclusive of 
exercise were included as individual intervention strata. Mean values were plotted with 
associated error bars using forest plots. Statistically significant results were identified 
as confidence intervals excluding a null effect and p value<0.05. Heterogeneity was 
assessed through examination of the forest plots and quantified using the I2 statistic. 
I2 statistics were graded according to Cochrane interpretation (>75% 
considerable/large heterogeneity). Reporting bias was assessed by plotting a funnel 
plot of intervention effect on blood pressure (Supplement S1).  
We completed meta-analysis according to Cochrane methods,27 using RevMan 
version 5.2 statistical software.28 A random-effects model was the default to 
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incorporate heterogeneity between studies, the inverse variance method was used to 
calculate the overall effect and standard error.29   
Planned subgroup analysis of included studies was completed according to the 
following co-variants: 1) Baseline blood pressure, 2) Baseline weight 3) Delivery 
method, whether exercise was self-directed or supervised 4) Estimated contact time 
between participants and intervention, 5) Target intensity of exercise, 6) Change in 
weight following intervention (Supplement S1).  
Meta-regression analysis was performed using the Wilson (2010) SPSS macro using 
IBM SPSS Statistics for Windows, Version 22.0.30 Meta-regression was performed 
using a random effects model to examine whether study level covariates (potential 
effect modifiers) predict intervention effect on systolic and diastolic blood pressure 
between studies at 3 to 6 months follow-up. A priori the following factors where agreed 
for inclusion in the meta-regression model; 1) Mean arterial blood pressure (MAP) 
combining systolic and diastolic blood pressure, 2) Estimated contact time between 
participants and intervention 3) Target exercise intensity during intervention 4) Effect 
of intervention on weight loss calculated as the standard mean difference between 
intervention and control post intervention to allow comparison between studies 
reporting change in weight and body mass index (Supplement Figure S3a-b).  
RESULTS 
Results of Search 
We screened 9524 titles and abstracts reviewing 786 full text articles (Figure 1). We 
identified 14 RCTs with 20 exercise intervention arms for inclusion, published between 
1985 and 2015 (Table 1, Table S2). The RCTs randomized 3614 participants with a 
recognised cardiovascular risk factor, mean age 42.2 years (SD 6.3). Over 75% of 
7 
 
participants were Caucasian and only 35% were female (Table 1). The studies 
recruited pre-hypertensive and stage 1 hypertensive participants. The majority of 
stage 1 hypertensives were not medicated at time of intervention, one study included 
participants that continued with antihypertensive prescription (n=15). 
Excluded studies, with explanation of exclusion listed in online supplement (Table S3).  
The major reason for study exclusion was age of population outside inclusion criteria 
(n=323) (Figure 1). 158 of these studies reported blood pressure as a primary 
outcome, of these, 73 studies excluded participants below 35 years old. None of the 
excluded cardiovascular studies performed subgroup analysis separating intervention 
effects by age. Other common explanations for study exclusion included non-RCT 
design or lack of true exercise control arms (n=181), or study objectives focused on 
acute or short term exercise response, primarily in healthy participants (n=51).  
Description of Included Studies 
The majority of participants received a combined behavioural intervention with a 
defined physical activity strategy (Table S2). 18 intervention exercise arms targeted 
increase in moderate to vigorous physical activity, 12 intervention arms delivered 
structured, supervised aerobic exercise programmes in gym and group environments 
with intensity defined by baseline exercise testing. Seven trial intervention arms 
promoted self-directed increase in physical activity supported by regular group and 
individual counselling sessions. Behavioural counselling was delivered by multi-
disciplinary professional groups. Contact time with the intervention in the first 3 months 
ranged from 5 to 48 hours, average 25 hours. The average in the first 3 months for 
studies reporting 3 to 6 month outcome was 30 hours (Table S2). The minimum follow-
up for inclusion in the present systematic review was 3 months, 10 studies report 3 to 
6 months follow-up data (15 intervention arms, n=2716). Five studies complete follow-
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up at three months and 6 studies report follow-up after 12 months (8 intervention arms, 
n=3023, Table S2).  
Risk of Bias and Quality Assessment 
The funnel plot of intervention effect on systolic blood pressure was symmetrical about 
the mean effect size line suggesting there was no particular study publication bias 
(Supplement Figure S1).  Overall quality of the included RCTs using the GRADE 
approach suggests moderate quality data (Supplement Figure S2). In total, nine 
studies are downgraded secondary to study design and outcome reporting being 
unclear or at risk of bias with limited reporting of participant allocation methods and 
lack of clarification of blinding during outcome assessment. A significant limitation of 
the included studies was the lack of reference to published study protocols that adhere 
to the TIDieR template.31 Only the Trials of Hypertension Prevention (TOHP) and 
ProActive UK studies consistently reference published study protocols (Supplement 
S3, Table S2).  
Participant compliance with intervention and effect on cardiovascular fitness 
and weight 
The majority of studies reported over 80% participant compliance with intervention at 
3-6 months, recorded as attendance at supervised classes and group meetings, or 
achievement of behavioural targets such as self-reported minutes of activity.  
However, compliance with behavioural targets dropped to an estimated 40% beyond 
12 months.  
Eight intervention arms deliver exercise in combination with weight management, 4 of 
these interventions report a significant reduction in weight loss compared to control at 
3-6 months (Supplement Figure S3a). Dietary assessment was undertaken using self-
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report diaries over periods of 1 to 7 days. The majority of studies use diary cards as 
aids to behaviour change as opposed to assessing compliance, only three studies 
report the change in dietary intake.  Mean cardiovascular fitness was reported from 14 
intervention arms, the median increase was 12% improvement in peak exercise 
capacity (range 3% to 30%).   
Intervention Effect on Blood Pressure 
Forest plots for mean differences in systolic and diastolic blood pressure after 3-6 
months of intervention are presented in Figure 2 (Supplement Figure S4a-b).  Mean 
difference in systolic blood pressure was -4.40 mmHg (95%CI, -5.78, -3.01) and -4.17 
mmHg (95%CI, -5.42, -2.93) for diastolic blood pressure when intervention was 
compared with control.  
There are no significant differences between intervention and control group blood 
pressures when followed up at, or beyond, 12 months (Figure 2, Supplement S5a-b). 
Mean difference in systolic blood pressure -1.02 mmHg (95%CI, -2.34 to 0.29) and 
mean difference in diastolic blood pressure was –0.91 mmHg (95%CI, -1.85 to 0.02). 
Subgroup Analysis  
I2 Statistic identified moderate to considerable heterogeneity across the studies (56% 
to 72%) at 3 to 6 month follow-up. Subgroup analysis did not provide a consistent 
explanation for heterogeneity between studies for both systolic and diastolic blood 
pressure. I2 Statistic reduced to below 45% for systolic blood pressure when analysis 
was restricted to hypertensive groups, groups with baseline weight above 90kg and 
self-directed intervention. (Table 2). 
Supervised aerobic exercise, higher exercise intensity and increased contact time with 
intervention were associated with larger reductions in systolic and diastolic blood 
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pressures (Table 2). Reduction in diastolic blood pressure was significantly greater 
when comparing supervised (-5.43 mmHg [95%Cl, -7.58, -3.28]) with self-directed 
exercise (-2.64 mmHg [95%Cl, -3.20, -2.08]) and when intervention targeted higher 
intensity compared to moderate intensity.  Blood pressure reductions appeared 
greater in association with over 4 kilogram weight loss, a weight loss threshold 
identified from previous systematic review.32  However, observed differences did not 
reach significance (systolic BP -5.03 mmHg [95%CI, -6.89, -3.17] vs -2.61 mmHg 
[95%CI, -5.77, 0.55] and diastolic BP -4.77 mmHg, [95%CI, -6.54, -2.99] vs -2.95 
mmHg [95%CI,-4.76, -1.13]).  There were no significant differences in intervention 
effect when groups were separated as hypertensive or pre-hypertensive at baseline 
(Table 2). 
Meta-regression 
The a priori meta-regression model explained 50% of variance in intervention effect 
on systolic blood pressure. Increased intensity of exercise and hours of contact with 
the intervention were significantly associated with reduction in systolic blood pressure 
(Table 3). Baseline mean arterial blood pressure and standard mean difference in 
weight loss (Supplement Figure S3a) between exercise and control groups post 
intervention were not significant predictors of mean reduction in systolic blood 
pressure. The a priori model did not provide significant explanation for variance in 
diastolic blood pressure response.   
DISCUSSION 
This is the first systematic review to apply age criteria to evaluate the RCT evidence 
base to promote exercise to prevent and manage hypertension in younger adults. In 
the short-term (3 to 6 months), exercise and physical activity interventions are 
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beneficial, with between 4 to 5 mmHg reductions in blood pressure. This is a larger 
effect than reported from a recent review reporting results from older adult groups and 
pre-hypertension groups.22 This may be explained by selection criteria, we excluded 
normotensive cohorts with no cardiovascular risk factors. Alternatively, the result may 
suggest that younger adults may be more responsive to exercise as an intervention to 
lower blood pressure. There were also comparable benefits in blood pressure 
reduction for both prehypertension and hypertension groups which has not been 
observed previously in older adult groups.22 Early adulthood may be an important life 
stage to target cardiovascular risk reduction. It is identified as a period where at risk 
groups present with hypertension.7 In addition, adverse cardiovascular risk profiles in 
early adulthood are predictive of future morbidity.17,33,34 Transition to early adulthood 
is identified as a period of decline in physical activity,35 with low fitness in early 
adulthood predictive of cardio-metabolic dysfunction in middle age36,37. In contrast, 
maintained or increased cardiovascular fitness in younger adults can change 
cardiovascular risk trajectory16,38. However, a dominant finding is that we have not 
observed any sustained effects in blood pressure reduction from studies reporting 
outcomes after 12 months. This is the first review in the blood pressure literature to 
explore the sustained effects of exercise intervention and the first to exclude studies 
with less than 3 months follow-up, which may have previously contributed to 
overestimation of effect.22,39 Our reported findings are similar to patterns observed in 
the general physical activity literature with a longitudinal decline in compliance with 
maintaining physical activity. The current evidence supports the need to build more 
detailed physical activity recommendations for hypertension management in younger 
adult populations.  
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Current guidelines recommend review of adults under 40 years of age with elevated 
blood pressure for exclusion of secondary causes of hypertension.19 The age inclusion 
criteria for this review were defined to align with this practice. However, a major 
limitation is the paucity of studies recruiting younger adults. Hypertension in younger 
adults is complicated by high rates of under-diagnosis and, when identified, sub-
optimal treatment.5,12–14 These deficiencies may reflect broader misconception that 
younger age is sufficiently protective against cardiovascular risk.5,12–14 This pattern is 
reflected in this review with an observed age bias for study recruitment in favour of 
older adults. The majority of excluded trials recruit cohorts over 50 years of age. In 
addition, over 46% of studies reporting blood pressure as a primary outcome excluded 
participants under 35 years of age.  
Improved risk evaluation and interpretation of the benefits of blood pressure reduction 
may facilitate discussion on how to reform hypertension management for younger 
adults.  An example is clinical interpretation of the reported 4 to 5 mmHg reduction in 
blood pressure, if this was sustained in a younger adult cohort with prehypertension, 
the estimated 5 year incidence of hypertension would reduce from 1 in 5 to 1 in 10.40 
This interpretation may be more beneficial than prediction of 10 year risk of 
cardiovascular events which is difficult in younger adults.41,42 However, long-term 
benefits on cardiovascular endpoints can be estimated;  a sustained 2 mmHg 
reduction in blood pressure could translate to 7% to 10% reduction in stroke and 
ischaemic cardiovascular event.9  The major challenge is how to achieve sustained 
effect. In this review intervention effect dropped to 1 mmHg by 12 months with no 
significant difference compared to control.  
To provide a platform to improve future intervention design we present an evaluation 
of study level characteristics that predict intervention effect at 3 to 6 months. With 
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regards intervention strategy and delivery, both supervised and self-directed exercise 
achieve reduction in blood pressure, although effect was greater with supervised 
exercise. This may reflect a dose effect, supervised exercise was associated with 
increased exercise participation in the short-term. This group also achieved higher 
exercise intensity and increased cardiovascular fitness. However, higher volumes of 
planned contact time between participant and intervention, irrespective of intensity or 
self-directed exercise, was also associated with greater reduction in blood pressure at 
3 to 6 months. Explanation for the subgroup analyses may relate to distinctions 
between physiological and behavioural influences of intervention. The exposure to 
higher exercise intensity may drive a mechanism for change in blood pressure distinct 
from low level activity. Self-directed and lower intensity exercise had relatively lower 
effects on diastolic blood pressure which is consistent with previous observations that 
blood pressure responses differ with intervention strategy.22,23,32  
The finding that contact time, independent of intensity is associated with a positive 
influence on systolic blood pressure may support a beneficial effect of increased 
frequency of low to moderate activity. However, interpretation is limited without 
objective and repeated measures of physical activity behaviour which was not reported 
in studies with 3 to 6 month outcomes. Alternatively, planned contact, inclusive of 
telephone and remote contact may be a stimulus for sustained behaviour.  
Unfortunately, the pattern across studies is that as contact is withdrawn intervention 
effect declines. This is despite several studies implementing recommended behaviour 
strategies such as promotion of participant self-efficacy, activity planning, self-
monitoring and participant feedback.25,43 Participant motivation and self-efficacy are of 
particular relevance as, despite the low attrition rates, the included studies report 
decline in scheduled attendance and compliance with intervention targets from over 
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80% at 3 to 6 month to 40% at 18 months. There are currently no strategies that 
effectively address the challenge of promoting sustained long term physical activity 
behavioural change. A promising approach is personalised intervention supported by 
device assisted behavioural change and flexible communication strategies to better 
sustain effective intervention.43 The use of wearable activity monitors and physical 
activity tracking applications on mobile device can provide objective measures of 
behaviour, facilitate self-monitoring and allow real-time feedback. However, the 
resource demands of maintaining high contact time and technology supported 
behaviour change may be a barrier to clinical translation. Economic evaluation of 
effective interventions with reference to delivery cost and process evaluation of 
strategies to sustain participant engagement, motivation and compliance may help to 
drive innovation and overcome these barriers.  
Improvement in intervention design and delivery may also benefit from more 
transparency and disclosure of the specific methods and content of delivered 
communication strategies. There were often only brief summaries available, which 
described the professional team, if communication training was provided to the team, 
and broad categorical descriptors of intervention themes discussed with participants. 
In the current review, a number of studies focused communication strategies around 
weight loss, promoting exercise as a mechanism for weight loss. However, an 
interesting observation from the review which may help to guide the evolution of future 
studies is the patterns of intervention effect associated with weight loss. Previous 
review identified that weight loss greater than 4kg was required to achieve significant 
blood pressure reduction.32  However, in our review, short term benefits of exercise on 
blood pressure were seen even in those who did not achieve this degree of weight 
loss. This observation is supported by weight loss not being a significant effect modifier 
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in the regression model. The positive message is that in the short term, exercise is 
beneficial for blood pressure reduction independent of pre or post intervention weight. 
Distinguishing between the independent benefits of exercise and weight loss may 
facilitate effective communication and participant engagement strategies, especially 
when participants may be motivated by different health and well-being goals.  
Limitations 
Major limitations are the paucity of research studies recruiting younger adult or 
performing subgroup analysis defined by age. Included studies did not present results 
by age preventing analysis of effect in very early adulthood.  Evaluation of the available 
literature base would be strengthened by meta-analysis of individual participant data 
but this was outside the scope of the review. The results would be strengthened by 
using ambulatory blood pressures, only three studies reported ambulatory blood 
pressures in addition to clinic blood pressures.  Identification of effective intervention 
components is limited by several study level factors including; lack of objective 
measurement and tracking of physical activity behaviour, limited description of content 
and delivery of communication strategies and lack of disclosure of effectiveness of 
intermediate intervention process outputs such as strategies to maintain participant 
engagement and compliance. In the majority of studies there is also risk of bias in 
relation to participant allocation concealment and blinding of outcome assessors, with 
methods not discussed or unclear, which may risk overestimation of intervention 
effectiveness. However, overall the quality of included studies were moderate and 
funnel plots suggest no evidence of reporting bias, though caution in interpretation is 
required because of the small number of studies.   
 
16 
 
Perspectives 
This review raises concern that current clinical practice to promote lifestyle and 
exercise intervention risks suboptimal management of young adult hypertension. 
Although it has been pragmatic to assume that exercise will improve blood pressure 
in young adults, the available evidence suggests current intervention strategies do not 
maintain long-term benefit. Discussion with young adult patient and public groups 
highlight that lifestyle interventions remains an attractive alternative to starting 
potential lifelong prescriptions for blood pressure. However, short-term reduction in 
blood pressure reported in this review involved multiple contacts over time and delivery 
of targeted exercise prescription. These strategies generally required supervised 
exercise interventions which are expensive and currently not widely supported.44 A 
major challenge for the clinical research community is to design and evaluate 
interventions which target sustained increase in physical activity behaviour, 
accommodate potential for titration of exercise prescription and deliver improvement 
in the cost per quality adjusted life year. Translation of research findings into clinical 
practice may be improved by study design incorporating comparative adaptiveness 
evaluations and exploring interactive effects with prescription medication.  Going 
forward there appears to be a need for strategic overhaul of the approaches 
implemented in the prevention and management of young adult blood pressure. 
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Novelty and Significance 
What is New? 
An age defined review of randomized trials, with long term follow up, designed to 
assess effectiveness of exercise intervention for blood pressure reduction in younger 
adults.  
What is Relevant? 
Exercise intervention is beneficial for young adults in the short-term at 3-6 months but 
has no sustained effect at, or beyond, 12 months. Efficacy of intervention at 3 to 6 
months was dependent on intensity of exercise and contact time with intervention 
teams. 
Summary 
Current recommendations for lifestyle and exercise interventions risk undertreating 
younger adults. There is need for review of practice and development of affordable 
interventions that deliver appropriate dose of exercise and sustained behaviour 
change. 
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Table 1. Baseline description of study populations participating in RCTs 
included in meta-analysis 
Study Mean  
Age 
(sd) 
Age 
Range 
Female  
(%) 
Weight 
kg  
(sd) 
BMI 
kg/m2 
Intervention Group  
BP mmHg 
Systolic      Diastolic               
Control Group  
BP mmHg 
Systolic      Diastolic 
Duncan 1985 30·4 
(.) 
21-37 0 86·4 
(14) 
. 146·3(5·9) 94·3(4) 145(5·5) 93·3(3·8) 
Stamler  1989 37 
(3·5) 
30-44 13 84·3 
(11) 
. 122·2(6·7) 82·4(2·8) 122·9(7) 82·6(3) 
Blumenthal 1991 
Aerobic Exercise 
45·2 
(7·8) 
29-59 38 82 
(13) 
27 141(9) 96(6) 142(12) 96(6) 
Blumenthal 1991 
Strength 
45·2 
(7·8) 
29-59 42 81 
(15) 
27·2 143(10) 95(5) 142(12) 96(6) 
Stevens   1993 
TOPH Weight Loss & 
Exercise 
42·8 
(6·1) 
30-54 32 89·7 
(13) 
29·5 124·3(8·4) 83·7(2·6) 124·6(8·1) 84(3) 
Whelton 1997 
TOHP Combined 
Lifestyle 
43·6 
(6·2) 
30-54 31 93·6 
(14·2) 
. 127·4(6·5) 86(1·9) 127·3(6·4) 85·8(1·9) 
Whelton 1997 
TOHP Weight Loss 
and Exercise 
43·4 
(6·1) 
30-54 37 93·4 
(14·1) 
. 127·6(6·1) 86(1·9) 127·3(6·4) 85·8(1·9) 
Blumenthal  2000  
Aerobic exercise 
46·6 
(8·8) 
>29 54 95·4 
(14·5) 
32·8 138·1(15·4) 93·6(7·3) 143·8(6·9) 94·4(3·4) 
Blumenthal  2000 
Aerobic exercise and 
Weight 
48·5 
(8·9) 
>29 62 93·3 
(17·7) 
32·1 142·7(10·4) 93·2(5·2) 143·8(6·9) 94·4(3·4) 
Tsai 2002 41 
(8·6) 
20-60 45.2 . 23·6 134·3(12·2) 85·3(10·2) 137·6(7·9) 91·6(7·9) 
Esposito 2003 34.6 
(5) 
20-46 100 94.5 
(9.3) 
34.8 124(8.5) 85(4.7) 123(7.9) 85(4.9) 
Olson 2006 38 
(6) 
24-44 30 38 
(6) 
27.6 119(7.7) 67(7.7) 119(11.6) 68(11.6) 
Kinmonth 2008 
In Person 
40.6 
(6) 
20-50 62 78.6 
(15.6) 
27.7 122.6(12.6) 77.9(9.0) 122.6(12.6) 78.2(9.0) 
Kinmonth 2008 
Telephone 
40.6 
(6) 
20-50 62 79.9 
(18) 
27.8 124.2(13.0) 79.1(10.6) 122.6(12.6) 78.2(9.0) 
Marquez-Celedonio 
2009 
43·2 
(7·8) 
30-55 . 78·1 
(15) 
31·2 133·0(4·4) 87·6(2·84) 132·7(4·2) 85·6(4·1) 
Knoepfli-Lenzin  
2010 Football 
37 
(4) 
20-45 0 82·1 
(8·7) 
26 134(7·0) 87(4·0) 134(4·0) 86(3) 
Knoepfli-Lenzin 2010 
Running 
36 
(5) 
20-45 0 87·3 
(9·4) 
26 136(9·0) 87(5·0) 134(4·0) 86(3) 
Edwards  2011  
Aerobic Exercise 
45·9 
(10·4) 
25-65 50 . 30·1 140·6(9·8) 89·8(11·2) 137·6(11·5) 88·2(9·2) 
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Edwards 2011 
Aerobic Exercise and 
Weight Loss 
45·9 
(10·4) 
25-65 50 . 31·2 139·9(10·5) 85·1(10) 137·6(11·5) 88·2(9·2) 
Krustrup 2012 46 
(7.3) 
31-54 0 97·8 
(13·6) 
30 151(10) 92(7) 153(8) 96(6) 
Mean values presented with standard deviations (sd). Gender distribution presented 
as percentage of females included. BMI: Body Mass Index (kg/m2). Missing or 
unreported values represented as (.). 
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Table 2. Subgroup analysis of effects of intervention on systolic and diastolic 
blood pressure according to study level characteristics.  
Group Intervention 
Arms 
N Systolic BP, mmHg Diastolic BP, mmHg 
Overall Intervention 
effect≤6months 
follow-up 
 
15 2716 -4·40 (-5·78, -3·01) 
I
2
=56%, Z=6·22 (p<0·00001) 
-4·17 (-5·42, -2·93) 
I
2
=72%, Z=6·57(p<0·00001) 
 
Intervention effect ≥ 
12months 
 
8 3023 -1·02 (-2·34, 0·29) 
I
2
=64%, Z=1·53 (p=0·13) 
-0.91 (-1·85, 0·02) 
I
2
=62%, Z=1.92 (p=0·06) 
Baseline Weight 
<90kg 
7 815 -3·0 (-6·04, 0·05) 
I
2
=72%, Z=1·93 (p=0·05) 
-3·88 (-6·13, -1·63) 
I
2
=73%, Z=3·38 (p=0·0007) 
≥90kg  
 
 
5 1806 -4·23(-5·49, -2·98) 
I
2
=32%, Z=6·6 (p<0·00001) 
-3·69 (-5·09, -2·30) 
I
2
=69%, Z=5·2 (p<0·0001) 
Baseline Systolic 
BP<140 mmHg and 
Diastolic<90 mmHg 
7 2370 -4·41 (-6·06, -2·77) 
I
2
=69%, Z=5·25 (P<0·00001) 
-3·87 (-5·33, -2·41) 
I
2
=77%, Z=5·20 (P<0·00001) 
Baseline Systolic 
BP≥140 mmHg and 
or Diastolic≥90 mmHg 
 
8 346 -4·35 (-7·26, -1·44) 
I
2
=42%, Z=2·93 (P=0·003) 
-4·55 (-6·91, -2·19) 
I
2
=62%, Z=3·78 (P=0·0002) 
Aerobic Supervised 
Exercise  
(follow-up≤6months) 
11 475 -5·40 (-8·08, -2·72) 
I
2
=56%, Z=3·95 (p<0·0001) 
-5·43 (-7·58, -3·28) 
I
2
=67%, Z=4·95 (P<0·00001) 
Self-directed physical 
activity  
(follow-up≤6months) 
 
3 2199 -3·81 (-4·52, -3·09) 
I
2
=0%, Z=10·39 (p<0·00001) 
-2·64 (-3·20, -2·08) 
I
2
=0%, Z=9·18 (p<0·00001) 
Weight Loss>4kg 6 1586 -5·03 (-6·89, -3·17) 
I
2
=65%, Z=5·31 (p<0·00001) 
-4·77 (-6·54, -2·99) 
I
2
=79%, Z=5·27 (p<0·00001) 
Weight Loss≤4kg 
 
 
6 1236 -2·61 (-5·77, 0·55) 
I
2
=61%, Z=2·07 (p=0·11) 
-2·95 (-4·76, -1·13) 
I
2
=53%, Z=3·18 (p=0·001) 
Moderate exercise 
intensity (≤ 60%) 
5 2265 -3.40 (-4.59, -2.21) 
I
2
=50%, Z=5.60 (P<0.0001) 
-2.58 (-3.13, -2.03) 
I
2
=0%, Z=9.14 (P<0.00001) 
Moderate to Vigorous 
intensity (>60%) 
 
10 451 -6.19 (-8.64, -3.73) 
I
2
=43%, Z=4.93 (P<0.0001) 
-5.92 (-8.09, -3.76) 
I
2
=64%,Z=5.36 (P<0.00001) 
Contact time less 
than 60 hours 
9 806 -2.83 (-5.33, -0.34) 
I
2
=46%, Z=2.23 (P=0.03) 
-3.91 (-6.33, -1.49) 
I
2
=67%, Z=3.16 (P=0.002) 
Contact time  
60 hours or more 
6 1910 -5.61 (-7.55, -3.67) 
I
2
=69%, Z=5.68 (P<0.00001) 
-4.57 (-6.22, -2.92) 
I
2
=80%, Z=5.42 (P<0.00001) 
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Results at 3 to 6 month follow-up used unless otherwise stated. Mean differences 
are pooled estimates from meta-analysis with 95% CIs. I2 values reported as 
measure of heterogeneity. Z scores with associated p values reported as test for 
overall effect. 
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Table 3. Meta-regression model comparing effect of study level covariates on 
post intervention systolic (1) and diastolic (2) blood pressure (mmHg) compared 
with control. 
 Model 1. Systolic Blood Pressure  Model 2. Diastolic Blood Pressure 
Variable 𝜷1 + SE CI (95%) Z(p) 𝜷1 + SE CI (95%) Z(p) 
       
MABP 
(mmHg) 
0.3161 + 
0.1625 
-0.0230,  0.6346  1.95 
(0.052) 
-0.0255 + 
0.1966 
-0.4108, 0.3599 -0.13 
(0.897) 
 
Hours of 
Contact 
-0.0718 + 
0.0336 
-0.1376, -0.0060 -2.14 
(0.032) 
 0.0192 + 
0.0404 
-0.0601, 0.0985  0.47 
(0.635) 
 
Exercise 
Intensity 
-0.1458 + 
0.0601 
-0.2636, -0.0281 -2.43 
(0.015) 
-0.1275 + 
0.0724 
-0.2695, 0.0144 -1.76 
(0.078) 
 
Weight 
Loss 
-0.9610 + 
1.6473 
-4.1897,  2.2677 -0.58 
(0.560) 
 2.1510 + 
1.9962 
-1.7615, 6.0635  1.08 
(0.281) 
   
Model statistics for systolic blood pressure R2 = 0.50, Q =16.4, df 4.0, p=0.0025.  
Model statistics for diastolic blood pressure R2 = 0.23 Q =4.95, df 4.0, p=0.293. 
Notes: MABP Mean Arterial Blood Pressure at baseline (mmHg); 𝛽1 + Standard Error; 
CI (95%), 95% confidence intervals; Z(p), z-score and alpha value.  
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Figure Legends  
 
Figure 1. PRISMA flow diagram describing the screening and selection of studies for 
inclusion in meta-analysis.  
Figure 2. Forest plot demonstrating mean difference in systolic and diastolic blood 
pressure (mmHg) after 3 to 6 months (A & B) and at, or beyond 12 months (C & D) 
follow-up. Included studies are all randomized control trial design delivering exercise 
and physical activity lifestyle intervention. Results for individual exercise intervention 
arms reported when available. Squares represent mean difference between 
intervention and control post intervention with 95% CIs, size of the square proportional 
to the weight of the study; pooled estimates from meta-analysis are depicted as solid 
black diamonds.  
 
 
